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Abstract
Data was collected from medical journals to assess changes in the nature and prevalence of
corporate sponsorship. The journals that reviewed were the Journal of the American Medical
Association (JAMA), the New England Journal of Medicine (NEJM), the British Medical
Journal (BMJ), and the Lancet. These journals were chosen because of their high impact on
medical research representing both American and British Medical editorials. It has been shown
that corporate sponsorship has been associated with bias results (Kjaergard et al 2002). Changes
in the nature of corporate sponsorship would be linked to changes in economic climate and
changes in the policies regarding how research is done and published. Data collected from the
four journals was used to determine several things: Significant changes in corporate sponsorship,
differences between European and American editorials, and a potential association between
subject and corporate sponsorship.
The consequences of temporal trends have a bearing on social policy because a bias in medical
research affects many large decisions, such as allocation of research funds, what medicines to
use on a personal level, and what research should be done in the future.
Similarities and differences were found in this study. American and British Periodicals both
showed an increase in For-profit sponsorship of Articles. The percentage of corporate
sponsorship has increased significantly more for the American periodicals. While American
Periodicals have roughly equal percentages of Private and Public coauthor affiliations, British
Periodicals show a stark difference. While American Periodicals are more likely to endorse a
project, the difference is only around 10 percent.

The Problem
There have been many allegations that corporate sponsorship has biased all fields of research
through funding. Gathering data on temporal trends in reported medical research could add
another dimension to the discussion of corporate sponsorship. If corporate sponsorship has taken
on a major role only recently, then an analysis of changes in policy could be done to see what led
to this change in funding. If recent changes in policies have led to a bias of research, then
perhaps those policies should be reevaluated.
This study aimed to make note of major temporal trends in the corporate sponsorship of
American and European editorials.

Background to the Problem
Questions about the link between the corporate funding of research and a potential bias started
with suspicions regarding studies funded by the tobacco industry (Turner and Spilich et al 1997).
Questions about a potential conflict of interest then began to be raised about other subjects. Some
of the first conversations regarding the need for financial disclosures and the role of potential
bias came when scandals occurred at noted medical journals such as the NEMJ (Angell and
Kassirer 1996) and the BMJ (Smith 1998).
In the following years many papers have been conducted which investigate the potential role of
corporate sponsorship and bias. Epidemiological studies of randomized clinical trials published
in various medical journals have shown that there is a distinct correlation between competing
interests and authors' conclusions (Kjaergard et al 2002). Studies have also been done to
determine if there is a difference between the methodology of tests funded by pharmaceutical

companies and those who list no competing interests. Articles were picked by well-defined
medical article database searches (Lexchin and Bero et al 2003).
Many papers have been written that investigate the relationship between pharmaceutical
companies and research. A paper by Resnik and Elliot identified five factors to determine
whether financial relationships are likely to enhance, undermine, or have no impact on the
credibility of research (Resnik and Elliot et al 2013). A paper by Wand and Murad offered
possible suggestions by which industry can potentially exert effects and propose new directions
for the future (Wand and Murad et al 2010).
The study I suggest would add to the collection of studies done by looking at a much larger
timespan, compare and contrast American and European editorials, and gathering more variables
than previous studies which may offer additional insights.

Research Design
The journals that have been chosen for this study were selected based on their high impact on
medical research. Two journals are American medical journals and two are British medical
journals. This selection allows for a comparison between American and European editorials.
From these journals a sampling of each publication year selected will be taken. Two issues from
a publication year will be selected – the first issue of the year and the first issue in July. From
these issues, the articles selected for review will be of the following categories: original
contributions, brief reports, reporting of cases, and laboratory technique notes. Articles that will
be excluded from the study include: editorials, book reviews, special communications,
corrections, letters, medical news, or any article that is not the result of data collection.

A rubric has been designed for this study that will gather the following data: number of
coauthors, if the article is international, the lead author, the lead author's institute, the lead
authors type of Institute (Hospital, University, Lab), whether the institute is public or private; the
last author, the last author's Institute, type of Institute (Hospital, University, Lab, or Government
Organization), whether the institute is public or private, coauthors collective affiliations; study
design (Clinical Study, Data Review, Drug Review, Equipment Review, Questionnaire, Report
of Case) , origin of funding (Public or Private), how funding was described (Grant, Chemicals, or
Equipment), and study subject, and if the study was in support of the product (Negative, Neutral,
or Positive).
Layout of the Rubric described above
Issue International Number of Coauthors First Author Lead Author's Institute Institute Type Public or Private

Last author Last Author's Institute Institute Type Public or Private Coauthors Affiliations

Is

Subject Endorsement of

Study Design Funding How was Funding Defined Study Subject Marketable

Product

Results
Figures 1-9 were generated from the data gathered using the rubric and collected in tables 1,2,3,
and 4 in the appendix. Figures 1-3 focused on the funding of articles. The figures went from
most general to more specific. Figures 4-6 focused on coauthors affiliations to a public or private
institute. Yet again the figures go from most general to most specific. Figures 7-9 focused on the
endorsement or non-endorsement of marketable subjects. The figures went from their most
general form to most specific. Figures 10 and 11 show the endorsement or lack of endorsement
of marketable subjects based on type of funding.

Figure 1. Pie chart representing the funding of articles from the year 1960-2015. This Pie chart is
independent of Time or distinction of periodical’s country.

Figure 2. Percentage of Articles which have any source of Corporate Sponsorship Independent of
Time.

Figure 3. Percentage of Articles which have any source of Corporate Sponsorship

Figure 4. Percentage of Coauthors belonging to a Private or Public Institute from 1960-2015.

Figure 5. Percentage of Coauthors belonging to a Private or Public Institute Independent of Time

Figure 6. Percentage of Coauthor Affiliations which were Private or a mix of Private and Public.

Figure 7. Percentage of marketable subjects that received or didn’t receive Endorsement
independent of Time or County

Figure 8. Percentage of marketable subjects that received or didn’t receive Endorsement
independent of Time

Figure 9. Percentage of marketable subjects that received or didn’t receive Endorsement by the
study reviewing them.

Figure 10. Sum of the endorsement or lack of endorsement of marketable subjects based on type
of funding for all four periodicals independent of time.

Figure 11. Endorsement or Lack of Endorsement of Marketable Subjects based on Type of
Funding Independent of Time

Discussion and Conclusion
As can be seen in Figure 3 two patterns are noticeable. The first trend is that the Percentage of
Articles which have any source of corporate sponsorship has increased for both the British and
American periodicals. The second trend is that the increase in the percentage of corporate
sponsorship has increased significantly more for the American periodicals. Figure 2 shows that
the types of Funding in American and British Articles were very similar. In fact for For-Profit
funding, independent of time, the rate was the same.
Figure 4 shows that while American Periodicals have roughly equal percentages of Private and
Public coauthor affiliations, British Periodicals show a stark difference. This pattern is expected
as a majority of British universities and hospitals are publically funded. As can be seen in Figure
6 the British Periodical does not show a change over the decades in percentage of coauthor
affiliations which were Private or a mix of Private and Public. Interestingly the American
Periodicals show a steady decrease, with the exception of the decade of the 2000s, in the
percentage of coauthor affiliations which were Private or a mix of Private and Public.
Figure 7 shows that a marketable subject which has an article written about it has a 65.4 percent
chance to be endorsed. Figure 8 shows that while American Periodicals are more likely to
endorse a project, the difference is only around 10 percent. Figure 9 shows that American
Periodicals are more likely to endorse a marketable product which is being reviewed. The reason
for this difference in percentage could be due to a number of factors such as: higher rates of
corporate sponsorship, differences in selection of marketable subjects to review, or differences in
concluding if a subject was successful or not.

Figures 10 and 11 are the strongest evidence of the biasing role of corporate sponsorship. It is
clearly shown that any article funded by corporate sponsorship is likely to endorse a marketable
subject. Additionally Figure 11 shows that American periodicals are more likely to have an
endorsement of marketable subjects based on if they have a corporate sponsor.
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